e-ISSN: Pending
Negative / Null Result ReportOpen accessMedical physics. Medical radiology. Nuclear medicine

Phase I and II trial on infusional 5-fluorouracil and gefitinib in combination with preoperative radiotherapy in rectal cancer: 10-years median follow-up

Maria Antonietta Gambacorta; Antonino De Paoli; Marco Lupattelli; Giuditta Chiloiro; Angela Pia Solazzo; Brunella Barbaro; Sergio Alfieri; Fabio Maria Vecchio · 2018 · Clinical and Translational Radiation Oncology

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Purpose: The aim of this study is to evaluate the long term survival of the addition of gefitinib to chemoradiotherapy (CRT) in locally advanced rectal cancer (LARC). Methods and materials: This previously published multicentre, open-label, phase I-II study, enrolled patients (pts) with LARC to receive CRT with concurrent 5-fluorouracil continuous intravenous infusion and a dose escalation of orally administered gefitinib, followed 6–8 weeks later by surgery. An intra-operative radiotherapy boost of 10 Gy was planned. Adjuvant chemotherapy was administrated in ypN1-2 pts. After a median f/u of

Abstract by Maria Antonietta Gambacorta; Antonino De Paoli; Marco Lupattelli; Giuditta Chiloiro; Angela Pia Solazzo; Brunella Barbaro; Sergio Alfieri; Fabio Maria Vecchio, Clinical and Translational Radiation Oncology (2018) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1016/j.ctro.2018.02.003